ARCHIVES

ASCO Annual Meeting: PARP Inhibitors Show Promise Against Breast Cancer In Small Phase II Studies

This article is from The Cancer Letter archive.

Vol. 35 No. 22 | June 5, 2009

Download PDF Visit The Full Archive

Related Articles

In Brief: AACR, ASCO to Sponsor Joint Symposium on Oncogenes; AACI Hosts Congressional Staff

February 15, 1985

Craig Thompson Of Abramson Center Named President, CEO, Of Memorial Sloan-Kettering

September 3, 2010

DeLap: Seven Years In industry Provided View Of Pressures On Drug Developers

August 2, 1996

NCI Predicts 42 Percent Increase In Number of Senior Survivors

October 28, 2011

On More Victory For Sol Garb: FDA Approves THC

June 14, 1985

Large Study Finds No Survival Benefit Associated With Removal Of Ovaries

January 30, 2009